Frontpage » Tag » latent tb

News tagged with latent tb


Technology brings new life to the study of diseases in old bones

A study led by The University of Manchester has demonstrated that new technology that can analyse millions of gene sequences in a matter of seconds is an effective way to quickly and accurately identify diseases in skeletons.

Medical research created Oct 22, 2012 | popularity not rated yet | comments 0 | with audio podcast

Team finds molecule that polices TB lung infection, could lead to vaccine

The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers ...

Diseases, Conditions, Syndromes created Jan 02, 2013 | popularity not rated yet | comments 0 | with audio podcast

Scientists gain new understanding of latent tuberculosis

Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available to fight TB for 50 years, the disease still infects nearly 2.2 billion people worldwide ...

Diseases, Conditions, Syndromes created Jan 30, 2013 | popularity not rated yet | comments 0

Scientists explain unique activity of TB drug pyrazinamide

Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood.

Medical research created Aug 11, 2011 | popularity not rated yet | comments 0 | with audio podcast

US urges shorter treatment for TB

US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.

Diseases, Conditions, Syndromes created Dec 08, 2011 | popularity not rated yet | comments 0

Vaccine targeting latent TB enters clinical testing

Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...

Medications created Dec 01, 2011 | popularity not rated yet | comments 0